Thus, based on the favorable results observed in human cells in vitro, we explored a similar strategy in the context of a mouse model of FA-A by integrating a therapeutic FANCA expression cassette into the murine Mbs85 gene, the ortholog of the human AAVS136–39. The gene discussed is FANCA; the disease is Fanconi anemia complementation group A.